Investing in local, often neglected brands has propelled Stada up the rankings of Europe’s leading OTC players. The Germany-based company believes it can displace Bayer as Europe’s number-three OTC supplier in the not too distant future with its Consumer Healthcare sales on an upward trajectory across the region.
Thinking Locally Propelling Stada CHC’s Rapid Growth In Europe
In this exclusive interview, Stada Consumer Healthcare's global head Volker Sydow discusses the company's growth ambitions for the business in Europe and further afield. Sydow outlines Stada CHC's local brand hero strategy, an approach which he says sets the firm apart from the competition.
More from Strategy
• By
Italy's Alfasigma has expanded its operation in Germany with the creation of a new Consumer Healthcare unit. Led by Rüdiger Hoppe, the business is rolling out OTC medical devices and dietary supplements in the gastrointestinal category.
• By
Arkopharma's parent company Dermapharm is undertaking a strategic shift at the French firm to help it better compete in the dietary supplements market after a tough year.
• By
Vitawell seeking to empower consumers left confused by the vast array of dietary supplements available to them in the UK.
• By
Chinese consumers are now routinely taking supplements for a variety of health reasons, helping to drive up sales of the Swisse Plus+ brand by 20% in 2024.
More from Business
• By
Chinese consumers are now routinely taking supplements for a variety of health reasons, helping to drive up sales of the Swisse Plus+ brand by 20% in 2024.
• By
Growing use of GLP-1 receptor agonists is having a positive knock-on effect on the dietary supplements market, reports OptiBiotix Health, marketer of the SlimBiome weight management prebiotic.
• By
By taking a majority stake in dynamic dietary supplements firm Braineffect, Germany's Schwabe can reach a new, younger target audience for its OTC herbal medicines.